Invention Grant
- Patent Title: Drugs for ameliorating postcibal hyperglycemia
- Patent Title (中): 用于改善后期高血糖症的药物
-
Application No.: US10485217Application Date: 2002-07-29
-
Publication No.: US07879869B2Publication Date: 2011-02-01
- Inventor: Kenzo Oba
- Applicant: Kenzo Oba
- Applicant Address: JP Osaka
- Assignee: Mitsubishi Tanabe Pharma Corporation
- Current Assignee: Mitsubishi Tanabe Pharma Corporation
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2001-229087 20010730
- International Application: PCT/JP02/07655 WO 20020729
- International Announcement: WO03/011308 WO 20030213
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C12Q1/02
Abstract:
It is mentioned to provide drugs for ameliorating postcibal hyperglycemia, drugs for inhibiting an increase in blood glucose level and pharmaceutical compositions for preventing or treating diabetes, each containing a pharmaceutically acceptable anion exchange resin typified by colestimide. Thus, it becomes possible to provide drugs clearly exhibiting an effect of inhibiting an increase in postcibal blood glucose level.
Public/Granted literature
- US20040191209A1 Drugs for ameliorating postcibal hyperglycemia Public/Granted day:2004-09-30
Information query
IPC分类:
